Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call

Ein Business-Meeting (Symbolbild). © gilaxia / E+ / Getty Images

PR Newswire

DAVIS, Calif., Oct. 27, 2022

DAVIS, Calif., Oct. 27, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022.

The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers:

U.S. Toll-Free Dial-In:

+1-866-374-5140

International Dial-In:

+1-404-400-0571

ARIVA.DE Börsen-Geflüster

Kurse

Arcadia Biosciences

2,14 $

+1,90%

Passcode:

14010760

A live webcast of the conference call will be available on the Investors section of Arcadia's website at www.arcadiabio.com. Following completion of the call, a recorded replay will be available on the company's investor website.

About Arcadia Biosciences, Inc.

Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating crops to provide high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products that make every body feel good, inside and out. The company's food, beverage and body care products include GoodWheat™, Zola^® coconut water, ProVault™ topical pain relief and SoulSpring™ bath and body care. For more information, visit www.arcadiabio.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-announces-date-of-third-quarter-2022-financial-results-and-business-highlights-conference-call-301660916.html

SOURCE Arcadia Biosciences, Inc.

Mehr Nachrichten zur Arcadia Biosciences Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.